Neuroprotective roles of the P2Y2 receptor

Purinergic Signalling

Volumn 8, Issue 3, 2012, Pages 559-578

  Weisman, Gary A ^a,b   Ajit, Deepa ^a,b   Garrad, Richard ^c   Peterson, Troy S ^b   Woods, Lucas T ^a,b   Thebeau, Christina ^a,b   Camden, Jean M ^a,b   Erb, Laurie ^a,b  

^a University of Missouri   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

^c MISSOURI STATE UNIVERSITY   (United States)

Author keywords

CNS; P2X and P2Y receptors; P2Y2 receptor

Indexed keywords

ADAM10 ENDOPEPTIDASE; ADENINE; ADENOSINE TRIPHOSPHATE; AMYLOID PRECURSOR PROTEIN; CALCIUM; EPIDERMAL GROWTH FACTOR RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; PURINERGIC P2X RECEPTOR; PURINERGIC P2X7 RECEPTOR; PURINERGIC P2Y2 RECEPTOR; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RHO KINASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; URIDINE; URIDINE TRIPHOSPHATE;

ALZHEIMER DISEASE; ARTICLE; BLOOD BRAIN BARRIER; BLOOD VESSEL PERMEABILITY; CALCIUM SIGNALING; CELL ADHESION; CELL COMMUNICATION; CELL INTERACTION; CELL JUNCTION; CELL MIGRATION; CELL SURVIVAL; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; GLIA CELL; HUMAN; INFLAMMATION; NERVE DEGENERATION; NEUROPROTECTION; NEUROTRANSMITTER RELEASE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; CENTRAL NERVOUS SYSTEM; ENDOTHELIUM; HUMANS; INFLAMMATION; NEUROGLIA; NEURONS; NEUROPROTECTIVE AGENTS; RECEPTORS, PURINERGIC P2X; RECEPTORS, PURINERGIC P2Y2; SIGNAL TRANSDUCTION;

EID: 84861527294     PISSN: 15739538     EISSN: 15739546     Source Type: Journal    
DOI: 10.1007/s11302-012-9307-6     Document Type: Article

References (277)

1. Burnstock G (2007) Physiology and pathophysiology of purinergic neurotransmission. Physiol Rev 87(2): 659-797.
2. Sak K, Webb TE (2002) A retrospective of recombinant P2Y receptor subtypes and their pharmacology. Arch Biochem Biophys 397(1): 131-136.
3. Inbe H, Watanabe S, Miyawaki M, Tanabe E, Encinas JA (2004) Identification and characterization of a cell-surface receptor, P2Y15, for AMP and adenosine. J Biol Chem 279(19): 19790-19799.
4. Abbracchio MP, Burnstock G, Boeynaems JM, Barnard EA, Boyer JL, Kennedy C, Knight GE, Fumagalli M, Gachet C, Jacobson KA, Weisman GA (2006) International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev 58(3): 281-341.
5. Turner JT, Weisman GA, Landon LA, Park M, Camden JM (1998) Salivary gland nucleotide receptors: evidence for functional expression of both P2X and P2Y subtypes. Eur J Morphol 36(Suppl): 170-175.
6. Weisman GA, Yu N, Liao Z, Gonzalez F, Erb L, Seye CI (2006) P2 receptors in health and disease. Biotechnol Genet Eng Rev 22: 171-195.
7. Erb L, Liao Z, Seye CI, Weisman GA (2006) P2 receptors: intracellular signaling. Pflugers Arch 452(5): 552-562.
8. Burnstock G, Wood JN (1996) Purinergic receptors: their role in nociception and primary afferent neurotransmission. Curr Opin Neurobiol 6(4): 526-532.
9. Neary JT, Rathbone MP, Cattabeni F, Abbracchio MP, Burnstock G (1996) Trophic actions of extracellular nucleotides and nucleosides on glial and neuronal cells. Trends Neurosci 19(1): 13-18.
10. Illes P, Alexandre Ribeiro J (2004) Molecular physiology of P2 receptors in the central nervous system. Eur J Pharmacol 483(1): 5-17.
11. Neary JT, Zimmermann H (2009) Trophic functions of nucleotides in the central nervous system. Trends Neurosci 32(4): 189-198.
12. Koles L, Leichsenring A, Rubini P, Illes P (2011) P2 receptor signaling in neurons and glial cells of the central nervous system. Adv Pharmacol 61: 441-493.
13. 2 nucleotide receptors inhibit trauma-induced death of astrocytic cells. J Neurochem 103(5): 1785-1800.
14. Inoue K (2008) Purinergic systems in microglia. Cell Mol Life Sci 65(19): 3074-3080.
15. 2 nucleotide receptor-mediated responses in brain cells. Mol Neurobiol 41(2-3): 356-366.
16. Suzuki T, Hide I, Ido K, Kohsaka S, Inoue K, Nakata Y (2004) Production and release of neuroprotective tumor necrosis factor by P2X7 receptor-activated microglia. J Neurosci 24(1): 1-7.
17. Bodin P, Burnstock G (2001) Purinergic signalling: ATP release. Neurochem Res 26(8-9): 959-969.
18. Butt AM (2011) ATP: a ubiquitous gliotransmitter integrating neuron-glial networks. Semin Cell Dev Biol 22(2): 205-213.
19. Molliver DC, Cook SP, Carlsten JA, Wright DE, McCleskey EW (2002) ATP and UTP excite sensory neurons and induce CREB phosphorylation through the metabotropic receptor, P2Y2. Eur J Neurosci 16(10): 1850-1860.
20. 2 nucleotide receptor function: implications for proliferative and inflammatory pathways in astrocytes. Mol Neurobiol 31(1-3): 169-183.
21. i elevation can substitute for receptor activation. J Biol Chem 273(36): 23110-23117.
22. 2 nucleotide receptor interact with Src and regulate activities of Src, proline-rich tyrosine kinase 2, and growth factor receptors. J Biol Chem 279(9): 8212-8218.
23. o-mediated signal transduction. J Cell Biol 153(3): 491-501.
24. o and induce cell migration. J Biol Chem 280(47): 39050-39057.
25. Franke H, Illes P (2006) Involvement of P2 receptors in the growth and survival of neurons in the CNS. Pharmacol Ther 109(3): 297-324.
26. Chen Y, Yao Y, Sumi Y, Li A, To UK, Elkhal A, Inoue Y, Woehrle T, Zhang Q, Hauser C, Junger WG (2010) Purinergic signaling: a fundamental mechanism in neutrophil activation. Sci Signal 3(125): ra45.
27. 2 receptor activates nerve growth factor/TrkA signaling to enhance neuronal differentiation. Proc Natl Acad Sci U S A 102(52): 19138-19143.
28. -/- mice. J Biol Chem 274(37): 26454-26460.
29. Burnstock G, Fredholm BB, North RA, Verkhratsky A (2010) The birth and postnatal development of purinergic signalling. Acta Physiol (Oxf) 199(2): 93-147.
30. Novak I (2008) Purinergic receptors in the endocrine and exocrine pancreas. Purinergic Signal 4(3): 237-253.
31. Burnstock G, Verkhratsky A (2010) Long-term (trophic) purinergic signalling: purinoceptors control cell proliferation, differentiation and death. Cell Death Dis 1: e9.
32. Burnstock G (2009) Purinergic signalling: past, present and future. Braz J Med Biol Res 42(1): 3-8.
33. Burnstock G, Dumsday B, Smythe A (1972) Atropine resistant excitation of the urinary bladder: the possibility of transmission via nerves releasing a purine nucleotide. Br J Pharmacol 44(3): 451-461.
34. Bowser DN, Khakh BS (2007) Vesicular ATP is the predominant cause of intercellular calcium waves in astrocytes. J Gen Physiol 129(6): 485-491.
35. Coco S, Calegari F, Pravettoni E, Pozzi D, Taverna E, Rosa P, Matteoli M, Verderio C (2003) Storage and release of ATP from astrocytes in culture. J Biol Chem 278(2): 1354-1362.
36. Guthrie PB, Knappenberger J, Segal M, Bennett MV, Charles AC, Kater SB (1999) ATP released from astrocytes mediates glial calcium waves. J Neurosci 19(2): 520-528.
37. Iwabuchi S, Kawahara K (2011) Functional significance of the negative-feedback regulation of ATP release via pannexin-1 hemichannels under ischemic stress in astrocytes. Neurochem Int 58(3): 376-384.
38. 2 nucleotide receptors enhance α-secretase-dependent amyloid precursor protein processing. J Biol Chem 280(19): 18696-18702.
39. Villa G, Fumagalli M, Verderio C, Abbracchio MP, Ceruti S (2010) Expression and contribution of satellite glial cells purinoceptors to pain transmission in sensory ganglia: an update. Neuron Glia Biol 6(1): 31-42.
40. Tran MD (2011) P2 receptor stimulation induces amyloid precursor protein production and secretion in rat cortical astrocytes. Neurosci Lett 492(3): 155-159.
41. Fumagalli M, Brambilla R, D'Ambrosi N, Volonte C, Matteoli M, Verderio C, Abbracchio MP (2003) Nucleotide-mediated calcium signaling in rat cortical astrocytes: role of P2X and P2Y receptors. Glia 43(3): 218-303.
42. Kreda SM, Seminario-Vidal L, Heusden C, Lazarowski ER (2008) Thrombin-promoted release of UDP-glucose from human astrocytoma cells. Br J Pharmacol 153(7): 1528-1537.
43. Brandenburg LO, Jansen S, Wruck CJ, Lucius R, Pufe T (2010) Antimicrobial peptide rCRAMP induced glial cell activation through P2Y receptor signalling pathways. Mol Immunol 47(10): 1905-1913.
44. Carter RL, Fricks IP, Barrett MO, Burianek LE, Zhou Y, Ko H, Das A, Jacobson KA, Lazarowski ER, Harden TK (2009) Quantification of Gi-mediated inhibition of adenylyl cyclase activity reveals that UDP is a potent agonist of the human P2Y14 receptor. Mol Pharmacol 76(6): 1341-1348.
45. 2Y purinoceptor subtypes recruit different mek activators in astrocytes. Br J Pharmacol 129(5): 927-936.
46. Jacques-Silva MC, Rodnight R, Lenz G, Liao Z, Kong Q, Tran M, Kang Y, Gonzalez FA, Weisman GA, Neary JT (2004) P2X7 receptors stimulate AKT phosphorylation in astrocytes. Br J Pharmacol 141(7): 1106-1117.
47. 7 nucleotide receptors mediate caspase-8/9/3-dependent apoptosis in rat primary cortical neurons. Purinergic Signal 1(4): 337-347.
48. 2 receptor. J Neurochem 109(5): 1300-1310.
49. 13 receptor activates the Nrf2/HO-1 axis and protects against oxidative stress-induced neuronal death. Free Radic Biol Med 49(3): 416-426.
50. Wang L, Jacobsen SE, Bengtsson A, Erlinge D (2004) P2 receptor mRNA expression profiles in human lymphocytes, monocytes and CD34+ stem and progenitor cells. BMC Immunol 5: 16.
51. Wang L, Karlsson L, Moses S, Hultgardh-Nilsson A, Andersson M, Borna C, Gudbjartsson T, Jern S, Erlinge D (2002) P2 receptor expression profiles in human vascular smooth muscle and endothelial cells. J Cardiovasc Pharmacol 40(6): 841-853.
52. Grassi F (2010) Purinergic control of neutrophil activation. J Mol Cell Biol 2(4): 176-177.
53. 2A receptor expression and function in equine monocytes. Vet Immunol Immunopathol 135(3-4): 289-295.
54. Chavez-Valdez R, Wills-Karp M, Ahlawat R, Cristofalo EA, Nathan A, Gauda EB (2009) Caffeine modulates TNF-α production by cord blood monocytes: the role of adenosine receptors. Pediatr Res 65(2): 203-208.
55. Rizzo R, Ferrari D, Melchiorri L, Stignani M, Gulinelli S, Baricordi OR, Di Virgilio F (2009) Extracellular ATP acting at the P2X7 receptor inhibits secretion of soluble HLA-G from human monocytes. J Immunol 183(7): 4302-4311.
56. 6 receptors on monocytes is required for TLR1/2-induced neutrophil migration by regulating IL-8 secretion. Eur J Immunol 39(10): 2885-2894.
57. 6 receptor and immunoinflammation. Neurosci Bull 25(3): 161-164.
58. Papp L, Balazsa T, Kofalvi A, Erdelyi F, Szabo G, Vizi ES, Sperlagh B (2004) P2X receptor activation elicits transporter-mediated noradrenaline release from rat hippocampal slices. J Pharmacol Exp Ther 310(3): 973-980.
59. Sperlagh B, Vizi ES (1991) Effect of presynaptic P2 receptor stimulation on transmitter release. J Neurochem 56(5): 1466-1470.
60. Sperlagh B, Illes P (2007) Purinergic modulation of microglial cell activation. Purinergic Signal 3(1-2): 117-127.
61. Cunha RA, Ribeiro JA (2000) ATP as a presynaptic modulator. Life Sci 68(2): 119-137.
62. Rodrigues RJ, Almeida T, Richardson PJ, Oliveira CR, Cunha RA (2005) Dual presynaptic control by ATP of glutamate release via facilitatory P2X1, P2X2/3, and P2X3 and inhibitory P2Y1, P2Y2, and/or P2Y4 receptors in the rat hippocampus. J Neurosci 25(27): 6286-6295.
63. Hussl S, Boehm S (2006) Functions of neuronal P2Y receptors. Pflugers Arch 452(5): 538-551.
64. Fischer W, Krugel U (2007) P2Y receptors: focus on structural, pharmacological and functional aspects in the brain. Curr Med Chem 14(23): 2429-2455.
65. Gerevich Z, Muller C, Illes P (2005) Metabotropic P2Y1 receptors inhibit P2X3 receptor-channels in rat dorsal root ganglion neurons. Eur J Pharmacol 521(1-3): 34-38.
66. Bianco F, Fumagalli M, Pravettoni E, D'Ambrosi N, Volonte C, Matteoli M, Abbracchio MP, Verderio C (2005) Pathophysiological roles of extracellular nucleotides in glial cells: differential expression of purinergic receptors in resting and activated microglia. Brain Res Brain Res Rev 48(2): 144-156.
67. Crain JM, Nikodemova M, Watters JJ (2009) Expression of P2 nucleotide receptors varies with age and sex in murine brain microglia. J Neuroinflammation 6: 24.
68. v integrin mediates astrocyte migration. J Neurochem 95(3): 630-640.
69. 12. FEBS Lett 513(2-3): 179-183.
70. Nicholas RA, Lazarowski ER, Watt WC, Li Q, Boyer J, Harden TK (1996) Pharmacological and second messenger signalling selectivities of cloned P2Y receptors. J Auton Pharmacol 16(6): 319-323.
71. Boyer JL, Zohn IE, Jacobson KA, Harden TK (1994) Differential effects of P2-purinoceptor antagonists on phospholipase C- and adenylyl cyclase-coupled P2Y-purinoceptors. Br J Pharmacol 113(2): 614-620.
72. Verkhratsky A, Krishtal OA, Burnstock G (2009) Purinoceptors on neuroglia. Mol Neurobiol 39(3): 190-208.
73. Lustig KD, Erb L, Landis DM, Hicks-Taylor CS, Zhang X, Sportiello MG, Weisman GA (1992) Mechanisms by which extracellular ATP and UTP stimulate the release of prostacyclin from bovine pulmonary artery endothelial cells. Biochim Biophys Acta 1134(1): 61-72.
74. 2U purinergic receptor. Proc Natl Acad Sci U S A 90(22): 10449-10453.
75. Sanz JM, Chiozzi P, Ferrari D, Colaianna M, Idzko M, Falzoni S, Fellin R, Trabace L, Di Virgilio F (2009) Activation of microglia by amyloid β requires P2X7 receptor expression. J Immunol 182(7): 4378-4385.
76. Di Virgilio F, Ceruti S, Bramanti P, Abbracchio MP (2009) Purinergic signalling in inflammation of the central nervous system. Trends Neurosci 32(2): 79-87.
77. 1 receptor signaling enhances neuroprotection by astrocytes against oxidative stress via IL-6 release in hippocampal cultures. Glia 57(3): 244-257.
78. 4 nucleotide receptors. Biochem Pharmacol 65(6): 923-931.
79. Chorna NE, Santiago-Perez LI, Erb L, Seye CI, Neary JT, Sun GY, Weisman GA, Gonzalez FA (2004) P2Y receptors activate neuroprotective mechanisms in astrocytic cells. J Neurochem 91(1): 119-132.
80. 2+ signalling in glial cell pathology in the central nervous system. Eur J Pharmacol 447(2-3): 247-260.
81. Bergfeld GR, Forrester T (1992) Release of ATP from human erythrocytes in response to a brief period of hypoxia and hypercapnia. Cardiovasc Res 26(1): 40-47.
82. Ostrom RS, Gregorian C, Drenan RM, Gabot K, Rana BK, Insel PA (2001) Key role for constitutive cyclooxygenase-2 of MDCK cells in basal signaling and response to released ATP. Am J Physiol Cell Physiol 281(2): C524-C531.
83. Ahmed SM, Rzigalinski BA, Willoughby KA, Sitterding HA, Ellis EF (2000) Stretch-induced injury alters mitochondrial membrane potential and cellular ATP in cultured astrocytes and neurons. J Neurochem 74(5): 1951-1960.
84. Ciccarelli R, Di Iorio P, Giuliani P, D'Alimonte I, Ballerini P, Caciagli F, Rathbone MP (1999) Rat cultured astrocytes release guanine-based purines in basal conditions and after hypoxia/hypoglycemia. Glia 25(1): 93-98.
85. Pineau I, Lacroix S (2009) Endogenous signals initiating inflammation in the injured nervous system. Glia 57(4): 351-361.
86. 6 receptors. Cell Adh Migr 1(3): 131-132.
87. 2 receptor subtype from NG108-15 neuroblastoma x glioma hybrid cells. Prog Brain Res 120: 33-43.
88. 2 receptors by UTP and ATP stimulates mitogen-activated kinase activity through a pathway that involves related adhesion focal tyrosine kinase and protein kinase C. J Biol Chem 273(5): 2653-2660.
89. 2 nucleotide receptor mediates vascular cell adhesion molecule-1 expression through interaction with VEGF receptor-2 (KDR/Flk-1). J Biol Chem 279(34): 35679-35686.
90. 2 and TrkA receptors interact with Src family kinase for neuronal differentiation. Biochem Biophys Res Commun 347(3): 678-682.
91. 2 receptor through an epidermal growth factor receptor-transregulated mechanism. J Biol Chem 285(5): 2940-2950.
92. 2 nucleotide receptor mediates UTP-induced vascular cell adhesion molecule-1 expression in coronary artery endothelial cells. J Biol Chem 278(27): 24960-24965.
93. 2 nucleotide receptor activation up-regulates vascular cell adhesion molecule-1 expression and enhances lymphocyte adherence to a human submandibular gland cell line. Mol Immunol 45(1): 65-75.
94. 2 nucleotide receptors mediate metalloprotease-dependent phosphorylation of epidermal growth factor receptor and ErbB3 in human salivary gland cells. J Biol Chem 285(10): 7545-7555.
95. 12. J Cell Sci 120(Pt 9): 1654-1662.
96. Rice WR, Burton FM, Fiedeldey DT (1995) Cloning and expression of the alveolar type II cell P2u-purinergic receptor. Am J Respir Cell Mol Biol 12(1): 27-32.
97. Gresham HD, Adams SP, Brown EJ (1992) Ligand binding specificity of the leukocyte response integrin expressed by human neutrophils. J Biol Chem 267(20): 13895-13902.
98. Hautanen A, Gailit J, Mann DM, Ruoslahti E (1989) Effects of modifications of the RGD sequence and its context on recognition by the fibronectin receptor. J Biol Chem 264(3): 1437-1442.
99. Jang DH, Han JH, Lee SH, Lee YS, Park H, Kim H, Kaang BK (2005) Cofilin expression induces cofilin-actin rod formation and disrupts synaptic structure and function in Aplysia synapses. Proc Natl Acad Sci U S A 102(44): 16072-16077.
100. 2 nucleotide receptor to filamin A regulates migration of vascular smooth muscle cells. Circ Res 102(5): 581-588.
101. 2 nucleotide receptors mediate uridine 5′-triphosphate-induced intimal hyperplasia in collared rabbit carotid arteries. Circulation 106(21): 2720-2726.
102. 2 receptor regulates LPS-induced neutrophil transendothelial migration in vitro. Mol Immunol 47(5): 991-999.
103. Baker OJ, Camden JM, Redman RS, Jones JE, Seye CI, Erb L, Weisman GA (2008) Proinflammatory cytokines tumor necrosis factor-α and interferon-γ alter tight junction structure and function in the rat parotid gland Par-C10 cell line. Am J Physiol Cell Physiol 295(5): C1191-C1201.
104. 2 released by intestinal epithelial cells. J Immunol 183(7): 4521-4529.
105. Chakfe Y, Seguin R, Antel JP, Morissette C, Malo D, Henderson D, Seguela P (2002) ADP and AMP induce interleukin-1beta release from microglial cells through activation of ATP-primed P2X7 receptor channels. J Neurosci 22(8): 3061-3069.
106. Fields RD (2011) Nonsynaptic and nonvesicular ATP release from neurons and relevance to neuron-glia signaling. Semin Cell Dev Biol 22(2): 214-219.
107. 2+ signaling. J Neurosci 26(5): 1378-1385.
108. Pearson RA, Dale N, Llaudet E, Mobbs P (2005) ATP released via gap junction hemichannels from the pigment epithelium regulates neural retinal progenitor proliferation. Neuron 46(5): 731-744.
109. El Khoury J, Luster AD (2008) Mechanisms of microglia accumulation in Alzheimer's disease: therapeutic implications. Trends Pharmacol Sci 29(12): 626-632.
110. 2 nucleotide receptor. Consequences of truncation of the C terminus. J Biol Chem 273(45): 29437-29444.
111. 2 receptor. Mol Pharmacol 54(3): 485-494.
112. 2+ entry in mouse microglial cells. Neuroscience 86(3): 925-935.
113. Luttrell LM, Gesty-Palmer D (2010) Beyond desensitization: physiological relevance of arrestin-dependent signaling. Pharmacol Rev 62(2): 305-330.
114. Ferguson SS (2001) Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol Rev 53(1): 1-24.
115. Fong AM, Premont RT, Richardson RM, Yu YR, Lefkowitz RJ, Patel DD (2002) Defective lymphocyte chemotaxis in beta-arrestin2- and GRK6-deficient mice. Proc Natl Acad Sci U S A 99(11): 7478-7483.
116. Zoudilova M, Kumar P, Ge L, Wang P, Bokoch GM, DeFea KA (2007) Beta-arrestin-dependent regulation of the cofilin pathway downstream of protease-activated receptor-2. J Biol Chem 282(28): 20634-20646.
117. Scott MG, Pierotti V, Storez H, Lindberg E, Thuret A, Muntaner O, Labbe-Jullie C, Pitcher JA, Marullo S (2006) Cooperative regulation of extracellular signal-regulated kinase activation and cell shape change by filamin A and beta-arrestins. Mol Cell Biol 26(9): 3432-3445.
118. Noma T, Lemaire A, Naga Prasad SV, Barki-Harrington L, Tilley DG, Chen J, Le Corvoisier P, Violin JD, Wei H, Lefkowitz RJ, Rockman HA (2007) beta-Arrestin-mediated beta1-adrenergic receptor transactivation of the EGFR confers cardioprotection. J Clin Invest 117(9): 2445-2458.
119. Prenzel N, Zwick E, Daub H, Leserer M, Abraham R, Wallasch C, Ullrich A (1999) EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 402(6764): 884-888.
120. Sudo S, Tanaka J, Toku K, Desaki J, Matsuda S, Arai T, Sakanaka M, Maeda N (1998) Neurons induce the activation of microglial cells in vitro. Exp Neurol 154(2): 499-510.
121. Shlosberg D, Benifla M, Kaufer D, Friedman A (2010) Blood-brain barrier breakdown as a therapeutic target in traumatic brain injury. Nat Rev Neurol 6(7): 393-403.
122. Barreto GE, Gonzalez J, Torres Y, Morales L (2011) Astrocytic-neuronal crosstalk: implications for neuroprotection from brain injury. Neurosci Res 71: 107-113.
123. Sugama S, Takenouchi T, Cho BP, Joh TH, Hashimoto M, Kitani H (2009) Possible roles of microglial cells for neurotoxicity in clinical neurodegenerative diseases and experimental animal models. Inflamm Allergy Drug Targets 8(4): 277-284.
124. Giaume C, Koulakoff A, Roux L, Holcman D, Rouach N (2010) Astroglial networks: a step further in neuroglial and gliovascular interactions. Nat Rev Neurosci 11(2): 87-99.
125. Simard M, Arcuino G, Takano T, Liu QS, Nedergaard M (2003) Signaling at the gliovascular interface. J Neurosci 23(27): 9254-9262.
126. Franke H, Krugel U, Grosche J, Heine C, Hartig W, Allgaier C, Illes P (2004) P2Y receptor expression on astrocytes in the nucleus accumbens of rats. Neuroscience 127(2): 431-441.
127. Streit WJ (2001) Microglia and macrophages in the developing CNS. Neurotoxicology 22(5): 619-624.
128. Kettenmann H, Hanisch UK, Noda M, Verkhratsky A (2011) Physiology of microglia. Physiol Rev 91(2): 461-553.
129. Kreutzberg GW (1996) Microglia: a sensor for pathological events in the CNS. Trends Neurosci 19(8): 312-318.
130. Streit WJ (2002) Microglia as neuroprotective, immunocompetent cells of the CNS. Glia 40(2): 133-139.
131. Butovsky O, Talpalar AE, Ben-Yaakov K, Schwartz M (2005) Activation of microglia by aggregated beta-amyloid or lipopolysaccharide impairs MHC-II expression and renders them cytotoxic whereas IFN-gamma and IL-4 render them protective. Mol Cell Neurosci 29(3): 381-393.
132. Turrin NP, Rivest S (2006) Tumor necrosis factor alpha but not interleukin 1 beta mediates neuroprotection in response to acute nitric oxide excitotoxicity. J Neurosci 26(1): 143-151.
133. Lalancette-Hebert M, Gowing G, Simard A, Weng YC, Kriz J (2007) Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain. J Neurosci 27(10): 2596-2605.
134. El Khoury J, Toft M, Hickman SE, Means TK, Terada K, Geula C, Luster AD (2007) Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nat Med 13(4): 432-438.
135. Neumann H, Takahashi K (2007) Essential role of the microglial triggering receptor expressed on myeloid cells-2 (TREM2) for central nervous tissue immune homeostasis. J Neuroimmunol 184(1-2): 92-99.
136. Boillee S, Yamanaka K, Lobsiger CS, Copeland NG, Jenkins NA, Kassiotis G, Kollias G, Cleveland DW (2006) Onset and progression in inherited ALS determined by motor neurons and microglia. Science 312(5778): 1389-1392.
137. Streit WJ (2006) Microglial senescence: does the brain's immune system have an expiration date? Trends Neurosci 29(9): 506-510.
138. Gate D, Rezai-Zadeh K, Jodry D, Rentsendorj A, Town T (2010) Macrophages in Alzheimer's disease: the blood-borne identity. J Neural Transm 117(8): 961-970.
139. Hawkes CA, McLaurin J (2009) Selective targeting of perivascular macrophages for clearance of beta-amyloid in cerebral amyloid angiopathy. Proc Natl Acad Sci U S A 106(4): 1261-1266.
140. Priller J, Flugel A, Wehner T, Boentert M, Haas CA, Prinz M, Fernandez-Klett F, Prass K, Bechmann I, de Boer BA, Frotscher M, Kreutzberg GW, Persons DA, Dirnagl U (2001) Targeting gene-modified hematopoietic cells to the central nervous system: use of green fluorescent protein uncovers microglial engraftment. Nat Med 7(12): 1356-1361.
141. Dickson DW (1999) Microglia in Alzheimer's disease and transgenic models. How close the fit? Am J Pathol 154(6): 1627-1631.
142. Brown GC, Neher JJ (2010) Inflammatory neurodegeneration and mechanisms of microglial killing of neurons. Mol Neurobiol 41(2-3): 242-247.
143. Elliott MR, Chekeni FB, Trampont PC, Lazarowski ER, Kadl A, Walk SF, Park D, Woodson RI, Ostankovich M, Sharma P, Lysiak JJ, Harden TK, Leitinger N, Ravichandran KS (2009) Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature 461(7261): 282-286.
144. 6 receptors is a mediator of microglial phagocytosis. Nature 446(7139): 1091-1095.
145. 2 receptor activation. J Neurochem. doi: 10. 1111/j. 1471-4159. 2012. 07700. x.
146. 12 receptor regulates microglial activation by extracellular nucleotides. Nat Neurosci 9(12): 1512-1519.
147. 12 signaling-dependent manner in the dorsal horn. Glia 58(15): 1838-1846.
148. Davalos D, Grutzendler J, Yang G, Kim JV, Zuo Y, Jung S, Littman DR, Dustin ML, Gan WB (2005) ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci 8(6): 752-758.
149. Ohsawa K, Irino Y, Nakamura Y, Akazawa C, Inoue K, Kohsaka S (2007) Involvement of P2X4 and P2Y12 receptors in ATP-induced microglial chemotaxis. Glia 55(6): 604-616.
150. Kronlage M, Song J, Sorokin L, Isfort K, Schwerdtle T, Leipziger J, Robaye B, Conley PB, Kim HC, Sargin S, Schon P, Schwab A, Hanley PJ (2010) Autocrine purinergic receptor signaling is essential for macrophage chemotaxis. Sci Signal 3(132): ra55.
151. 2 receptor mRNA in the cerebellum. Methods Mol Biol 326: 151-162.
152. Cheung KK, Ryten M, Burnstock G (2003) Abundant and dynamic expression of G protein-coupled P2Y receptors in mammalian development. Dev Dyn 228(2): 254-266.
153. Lee YJ, Han SB, Nam SY, Oh KW, Hong JT (2010) Inflammation and Alzheimer's disease. Arch Pharm Res 33(10): 1539-1556.
154. Takenouchi T, Sugama S, Iwamaru Y, Hashimoto M, Kitani H (2009) Modulation of the ATP-induced release and processing of IL-1beta in microglial cells. Crit Rev Immunol 29(4): 335-345.
155. Choi HB, Ryu JK, Kim SU, McLarnon JG (2007) Modulation of the purinergic P2X7 receptor attenuates lipopolysaccharide-mediated microglial activation and neuronal damage in inflamed brain. J Neurosci 27(18): 4957-4968.
156. Mingam R, De Smedt V, Amedee T, Bluthe RM, Kelley KW, Dantzer R, Laye S (2008) In vitro and in vivo evidence for a role of the P2X7 receptor in the release of IL-1 beta in the murine brain. Brain Behav Immun 22(2): 234-244.
157. Wullaert A, Bonnet MC, Pasparakis M (2011) NF-kappaB in the regulation of epithelial homeostasis and inflammation. Cell Res 21(1): 146-158.
158. Bamburg JR, Bloom GS (2009) Cytoskeletal pathologies of Alzheimer disease. Cell Motil Cytoskeleton 66(8): 635-649.
159. Pooler AM, Guez DH, Benedictus R, Wurtman RJ (2005) Uridine enhances neurite outgrowth in nerve growth factor-differentiated PC12. Neuroscience 134(1): 207-214.
160. Grimm I, Messemer N, Stanke M, Gachet C, Zimmermann H (2009) Coordinate pathways for nucleotide and EGF signaling in cultured adult neural progenitor cells. J Cell Sci 122(Pt 14): 2524-2533.
161. 2 receptor expression is altered in rats after spinal cord injury. Int J Dev Neurosci 28(6): 413-421.
162. Halassa MM, Fellin T, Haydon PG (2009) Tripartite synapses: roles for astrocytic purines in the control of synaptic physiology and behavior. Neuropharmacology 57(4): 343-346.
163. 2 receptor sensitizes mouse bladder sensory neurons and facilitates purinergic currents. J Neurosci 30(6): 2365-2372.
164. Bush CF, Jones SV, Lyle AN, Minneman KP, Ressler KJ, Hall RA (2007) Specificity of olfactory receptor interactions with other G protein-coupled receptors. J Biol Chem 282(26): 19042-19051.
165. 2 receptor and TRPV channel by ATP: implications for ATP induced pain. Cell Mol Neurobiol 25(5): 819-832.
166. 2 receptor agonist INS37217 enhances functional recovery after detachment caused by subretinal injection in normal and rds mice. Invest Ophthalmol Vis Sci 44(10): 4505-4514.
167. Pfrieger FW (2010) Role of glial cells in the formation and maintenance of synapses. Brain Res Rev 63(1-2): 39-46.
168. Newman EA (2003) New roles for astrocytes: regulation of synaptic transmission. Trends Neurosci 26(10): 536-542.
169. Araque A, Carmignoto G, Haydon PG (2001) Dynamic signaling between astrocytes and neurons. Annu Rev Physiol 63: 795-813.
170. Barker AJ, Ullian EM (2010) Astrocytes and synaptic plasticity. Neuroscientist 16(1): 40-50.
171. Vilhardt F (2005) Microglia: phagocyte and glia cell. Int J Biochem Cell Biol 37(1): 17-21.
172. Biber K, Neumann H, Inoue K, Boddeke HW (2007) Neuronal 'on' and 'off' signals control microglia. Trends Neurosci 30(11): 596-602.
173. Nimmerjahn A, Kirchhoff F, Helmchen F (2005) Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308(5726): 1314-1318.
174. Wake H, Moorhouse AJ, Jinno S, Kohsaka S, Nabekura J (2009) Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals. J Neurosci 29(13): 3974-3980.
175. Graeber MB, Bise K, Mehraein P (1993) Synaptic stripping in the human facial nucleus. Acta Neuropathol 86(2): 179-181.
176. Yamada J, Hayashi Y, Jinno S, Wu Z, Inoue K, Kohsaka S, Nakanishi H (2008) Reduced synaptic activity precedes synaptic stripping in vagal motoneurons after axotomy. Glia 56(13): 1448-1462.
177. Schipke CG, Boucsein C, Ohlemeyer C, Kirchhoff F, Kettenmann H (2002) Astrocyte Ca2+ waves trigger responses in microglial cells in brain slices. FASEB J 16(2): 255-257.
178. Verderio C, Matteoli M (2001) ATP mediates calcium signaling between astrocytes and microglial cells: modulation by IFN-gamma. J Immunol 166(10): 6383-6391.
179. de Haas AH, van Weering HR, de Jong EK, Boddeke HW, Biber KP (2007) Neuronal chemokines: versatile messengers in central nervous system cell interaction. Mol Neurobiol 36(2): 137-151.
180. Bessis A, Bechade C, Bernard D, Roumier A (2007) Microglial control of neuronal death and synaptic properties. Glia 55(3): 233-238.
181. Pocock JM, Kettenmann H (2007) Neurotransmitter receptors on microglia. Trends Neurosci 30(10): 527-535.
182. Nakajima K, Kikuchi Y, Ikoma E, Honda S, Ishikawa M, Liu Y, Kohsaka S (1998) Neurotrophins regulate the function of cultured microglia. Glia 24(3): 272-289.
183. Noda M, Nakanishi H, Nabekura J, Akaike N (2000) AMPA-kainate subtypes of glutamate receptor in rat cerebral microglia. J Neurosci 20(1): 251-258.
184. Inoue K (2006) The function of microglia through purinergic receptors: neuropathic pain and cytokine release. Pharmacol Ther 109(1-2): 210-226.
185. Farber K, Kettenmann H (2005) Physiology of microglial cells. Brain Res Brain Res Rev 48(2): 133-143.
186. Lessmann V, Gottmann K, Malcangio M (2003) Neurotrophin secretion: current facts and future prospects. Prog Neurobiol 69(5): 341-374.
187. Honda S, Sasaki Y, Ohsawa K, Imai Y, Nakamura Y, Inoue K, Kohsaka S (2001) Extracellular ATP or ADP induce chemotaxis of cultured microglia through Gi/o-coupled P2Y receptors. J Neurosci 21(6): 1975-1982.
188. Hamilton N, Vayro S, Wigley R, Butt AM (2010) Axons and astrocytes release ATP and glutamate to evoke calcium signals in NG2-glia. Glia 58(1): 66-79.
189. Hamilton N, Vayro S, Kirchhoff F, Verkhratsky A, Robbins J, Gorecki DC, Butt AM (2008) Mechanisms of ATP- and glutamate-mediated calcium signaling in white matter astrocytes. Glia 56(7): 734-749.
190. Boucsein C, Zacharias R, Farber K, Pavlovic S, Hanisch UK, Kettenmann H (2003) Purinergic receptors on microglial cells: functional expression in acute brain slices and modulation of microglial activation in vitro. Eur J Neurosci 17(11): 2267-2276.
191. 2+ mobilization and functional responses in microglia: effects of low levels of ATP. J Neurosci Res 81(3): 349-356.
192. Norenberg W, Langosch JM, Gebicke-Haerter PJ, Illes P (1994) Characterization and possible function of adenosine 5′-triphosphate receptors in activated rat microglia. Br J Pharmacol 111(3): 942-950.
193. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, Cooper NR, Eikelenboom P, Emmerling M, Fiebich BL, Finch CE, Frautschy S, Griffin WS, Hampel H, Hull M, Landreth G, Lue L, Mrak R, Mackenzie IR, McGeer PL, O'Banion MK, Pachter J, Pasinetti G, Plata-Salaman C, Rogers J, Rydel R, Shen Y, Streit W, Strohmeyer R, Tooyoma I, van Muiswinkel FL, Veerhuis R, Walker D, Webster S, Wegrzyniak B, Wenk G, Wyss-Coray T (2000) Inflammation and Alzheimer's disease. Neurobiol Aging 21(3): 383-421.
194. Nguyen MD, Julien JP, Rivest S (2002) Innate immunity: the missing link in neuroprotection and neurodegeneration? Nat Rev Neurosci 3(3): 216-227.
195. Rivest S (2009) Regulation of innate immune responses in the brain. Nat Rev Immunol 9(6): 429-439.
196. Pratico D, Uryu K, Sung S, Tang S, Trojanowski JQ, Lee VM (2002) Aluminum modulates brain amyloidosis through oxidative stress in APP transgenic mice. FASEB J 16(9): 1138-1140.
197. Zhu X, Raina AK, Lee HG, Casadesus G, Smith MA, Perry G (2004) Oxidative stress signalling in Alzheimer's disease. Brain Res 1000(1-2): 32-39.
198. Abramov AY, Canevari L, Duchen MR (2004) Calcium signals induced by amyloid beta peptide and their consequences in neurons and astrocytes in culture. Biochim Biophys Acta 1742(1-3): 81-87.
199. Jensen MD, Sheng W, Simonyi A, Johnson GS, Sun AY, Sun GY (2009) Involvement of oxidative pathways in cytokine-induced secretory phospholipase A2-IIA in astrocytes. Neurochem Int 55(6): 362-368.
200. Griffin WS (2006) Inflammation and neurodegenerative diseases. Am J Clin Nutr 83(2): 470S-474S.
201. Popovich PG, Longbrake EE (2008) Can the immune system be harnessed to repair the CNS? Nat Rev Neurosci 9(6): 481-493.
202. Benito C, Nunez E, Tolon RM, Carrier EJ, Rabano A, Hillard CJ, Romero J (2003) Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains. J Neurosci 23(35): 11136-11141.
203. Alarcon R, Fuenzalida C, Santibanez M, von Bernhardi R (2005) Expression of scavenger receptors in glial cells. Comparing the adhesion of astrocytes and microglia from neonatal rats to surface-bound beta-amyloid. J Biol Chem 280(34): 30406-30415.
204. Mouser PE, Head E, Ha KH, Rohn TT (2006) Caspase-mediated cleavage of glial fibrillary acidic protein within degenerating astrocytes of the Alzheimer's disease brain. Am J Pathol 168(3): 936-946.
205. Yin KJ, Cirrito JR, Yan P, Hu X, Xiao Q, Pan X, Bateman R, Song H, Hsu FF, Turk J, Xu J, Hsu CY, Mills JC, Holtzman DM, Lee JM (2006) Matrix metalloproteinases expressed by astrocytes mediate extracellular amyloid-beta peptide catabolism. J Neurosci 26(43): 10939-10948.
206. Ziabreva I, Perry E, Perry R, Minger SL, Ekonomou A, Przyborski S, Ballard C (2006) Altered neurogenesis in Alzheimer's disease. J Psychosom Res 61(3): 311-316.
207. Du Y, Fischer TZ, Lee LN, Lercher LD, Dreyfus CF (2003) Regionally specific effects of BDNF on oligodendrocytes. Dev Neurosci 25(2-4): 116-126.
208. Streit WJ (2005) Microglia and neuroprotection: implications for Alzheimer's disease. Brain Res Brain Res Rev 48(2): 234-239.
209. Seri B, Garcia-Verdugo JM, McEwen BS, Alvarez-Buylla A (2001) Astrocytes give rise to new neurons in the adult mammalian hippocampus. J Neurosci 21(18): 7153-7160.
210. Bours MJ, Dagnelie PC, Giuliani AL, Wesselius A, Di Virgilio F (2011) P2 receptors and extracellular ATP: a novel homeostatic pathway in inflammation. Front Biosci (Schol Ed) 3: 1443-1456.
211. Heneka MT, O'Banion MK (2007) Inflammatory processes in Alzheimer's disease. J Neuroimmunol 184(1-2): 69-91.
212. Campbell SJ, Deacon RM, Jiang Y, Ferrari C, Pitossi FJ, Anthony DC (2007) Overexpression of IL-1beta by adenoviral-mediated gene transfer in the rat brain causes a prolonged hepatic chemokine response, axonal injury and the suppression of spontaneous behaviour. Neurobiol Dis 27(2): 151-163.
213. Kuzumaki N, Ikegami D, Imai S, Narita M, Tamura R, Yajima M, Suzuki A, Miyashita K, Niikura K, Takeshima H, Ando T, Ushijima T, Suzuki T (2010) Enhanced IL-1beta production in response to the activation of hippocampal glial cells impairs neurogenesis in aged mice. Synapse 64(9): 721-728.
214. Shigemoto-Mogami Y, Koizumi S, Tsuda M, Ohsawa K, Kohsaka S, Inoue K (2001) Mechanisms underlying extracellular ATP-evoked interleukin-6 release in mouse microglial cell line, MG-5. J Neurochem 78(6): 1339-1349.
215. 2 receptor mRNA in astrocytes cultured from rat brain. Int J Immunopathol Pharmacol 20(2): 301-316.
216. Walker DG, Kim SU, McGeer PL (1995) Complement and cytokine gene expression in cultured microglial derived from postmortem human brains. J Neurosci Res 40(4): 478-493.
217. Pihlaja R, Koistinaho J, Malm T, Sikkila H, Vainio S, Koistinaho M (2008) Transplanted astrocytes internalize deposited beta-amyloid peptides in a transgenic mouse model of Alzheimer's disease. Glia 56(2): 154-163.
218. Mandrekar S, Jiang Q, Lee CY, Koenigsknecht-Talboo J, Holtzman DM, Landreth GE (2009) Microglia mediate the clearance of soluble Abeta through fluid phase macropinocytosis. J Neurosci 29(13): 4252-4262.
219. Wyss-Coray T, Lin C, Yan F, Yu GQ, Rohde M, McConlogue L, Masliah E, Mucke L (2001) TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice. Nat Med 7(5): 612-618.
220. Chung H, Brazil MI, Soe TT, Maxfield FR (1999) Uptake, degradation, and release of fibrillar and soluble forms of Alzheimer's amyloid beta-peptide by microglial cells. J Biol Chem 274(45): 32301-32308.
221. Kong Y, Ruan L, Qian L, Liu X, Le Y (2010) Norepinephrine promotes microglia to uptake and degrade amyloid beta peptide through upregulation of mouse formyl peptide receptor 2 and induction of insulin-degrading enzyme. J Neurosci 30(35): 11848-11857.
222. Schenk D, Barbour R, Dunn W, Gordon G, Grajeda H, Guido T, Hu K, Huang J, Johnson-Wood K, Khan K, Kholodenko D, Lee M, Liao Z, Lieberburg I, Motter R, Mutter L, Soriano F, Shopp G, Vasquez N, Vandevert C, Walker S, Wogulis M, Yednock T, Games D, Seubert P (1999) Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400(6740): 173-177.
223. Bard F, Cannon C, Barbour R, Burke RL, Games D, Grajeda H, Guido T, Hu K, Huang J, Johnson-Wood K, Khan K, Kholodenko D, Lee M, Lieberburg I, Motter R, Nguyen M, Soriano F, Vasquez N, Weiss K, Welch B, Seubert P, Schenk D, Yednock T (2000) Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med 6(8): 916-919.
224. Rogers J, Lue LF (2001) Microglial chemotaxis, activation, and phagocytosis of amyloid beta-peptide as linked phenomena in Alzheimer's disease. Neurochem Int 39(5-6): 333-340.
225. Marques-da-Silva C, Burnstock G, Ojcius DM, Coutinho-Silva R (2011) Purinergic receptor agonists modulate phagocytosis and clearance of apoptotic cells in macrophages. Immunobiology 216(1-2): 1-11.
226. 2Z purinoreceptor ligation induces activation of caspases with distinct roles in apoptotic and necrotic alterations of cell death. FEBS Lett 447(1): 71-75.
227. Ferrari D, Chiozzi P, Falzoni S, Dal Susino M, Collo G, Buell G, Di Virgilio F (1997) ATP-mediated cytotoxicity in microglial cells. Neuropharmacology 36(9): 1295-1301.
228. Wegiel J, Wang KC, Imaki H, Rubenstein R, Wronska A, Osuchowski M, Lipinski WJ, Walker LC, LeVine H (2001) The role of microglial cells and astrocytes in fibrillar plaque evolution in transgenic APP(SW) mice. Neurobiol Aging 22(1): 49-61.
229. Wegiel J, Imaki H, Wang KC, Wronska A, Osuchowski M, Rubenstein R (2003) Origin and turnover of microglial cells in fibrillar plaques of APPsw transgenic mice. Acta Neuropathol 105(4): 393-402.
230. Wegiel J, Imaki H, Wang KC, Rubenstein R (2004) Cells of monocyte/microglial lineage are involved in both microvessel amyloidosis and fibrillar plaque formation in APPsw tg mice. Brain Res 1022(1-2): 19-29.
231. Sheng JG, Mrak RE, Griffin WS (1997) Neuritic plaque evolution in Alzheimer's disease is accompanied by transition of activated microglia from primed to enlarged to phagocytic forms. Acta Neuropathol 94(1): 1-5.
232. Perlmutter LS, Scott SA, Barron E, Chui HC (1992) MHC class II-positive microglia in human brain: association with Alzheimer lesions. J Neurosci Res 33(4): 549-558.
233. Malm TM, Koistinaho M, Parepalo M, Vatanen T, Ooka A, Karlsson S, Koistinaho J (2005) Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to beta-amyloid deposition in APP/PS1 double transgenic Alzheimer mice. Neurobiol Dis 18(1): 134-142.
234. Itagaki S, McGeer PL, Akiyama H, Zhu S, Selkoe D (1989) Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease. J Neuroimmunol 24(3): 173-182.
235. Haga S, Akai K, Ishii T (1989) Demonstration of microglial cells in and around senile (neuritic) plaques in the Alzheimer brain. An immunohistochemical study using a novel monoclonal antibody. Acta Neuropathol 77(6): 569-575.
236. Frautschy SA, Yang F, Irrizarry M, Hyman B, Saido TC, Hsiao K, Cole GM (1998) Microglial response to amyloid plaques in APPsw transgenic mice. Am J Pathol 152(1): 307-317.
237. Dickson DW, Farlo J, Davies P, Crystal H, Fuld P, Yen SH (1988) Alzheimer's disease. A double-labeling immunohistochemical study of senile plaques. Am J Pathol 132(1): 86-101.
238. Simard AR, Soulet D, Gowing G, Julien JP, Rivest S (2006) Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron 49(4): 489-502.
239. Chen Y, Corriden R, Inoue Y, Yip L, Hashiguchi N, Zinkernagel A, Nizet V, Insel PA, Junger WG (2006) ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors. Science 314(5806): 1792-1795.
240. 2 receptor mediates chemotaxis of dendritic cells and eosinophils in allergic lung inflammation. Allergy 65(12): 1545-1553.
241. 2 receptor regulates VCAM-1 membrane and soluble forms and eosinophil accumulation during lung inflammation. J Immunol 185(6): 3702-3707.
242. van Buul JD, Hordijk PL (2004) Signaling in leukocyte transendothelial migration. Arterioscler Thromb Vasc Biol 24(5): 824-833.
243. Huang AJ, Manning JE, Bandak TM, Ratau MC, Hanser KR, Silverstein SC (1993) Endothelial cell cytosolic free calcium regulates neutrophil migration across monolayers of endothelial cells. J Cell Biol 120(6): 1371-1380.
244. 2 purinoceptor in intimal lesions of the rat aorta. Arterioscler Thromb Vasc Biol 17(12): 3602-3610.
245. Mehta D, Malik AB (2006) Signaling mechanisms regulating endothelial permeability. Physiol Rev 86(1): 279-367.
246. Wojciak-Stothard B, Ridley AJ (2002) Rho GTPases and the regulation of endothelial permeability. Vascul Pharmacol 39(4-5): 187-199.
247. Saito H, Minamiya Y, Saito S, Ogawa J (2002) Endothelial Rho and Rho kinase regulate neutrophil migration via endothelial myosin light chain phosphorylation. J Leukoc Biol 72(4): 829-836.
248. Wojciak-Stothard B, Potempa S, Eichholtz T, Ridley AJ (2001) Rho and Rac but not Cdc42 regulate endothelial cell permeability. J Cell Sci 114(Pt 7): 1343-1355.
249. Wojciak-Stothard B, Entwistle A, Garg R, Ridley AJ (1998) Regulation of TNF-alpha-induced reorganization of the actin cytoskeleton and cell-cell junctions by Rho, Rac, and Cdc42 in human endothelial cells. J Cell Physiol 176(1): 150-165.
250. Vouret-Craviari V, Boquet P, Pouyssegur J, van Obberghen-Schilling E (1998) Regulation of the actin cytoskeleton by thrombin in human endothelial cells: role of Rho proteins in endothelial barrier function. Mol Biol Cell 9(9): 2639-2653.
251. Soga N, Namba N, McAllister S, Cornelius L, Teitelbaum SL, Dowdy SF, Kawamura J, Hruska KA (2001) Rho family GTPases regulate VEGF-stimulated endothelial cell motility. Exp Cell Res 269(1): 73-87.
252. Rabiet MJ, Plantier JL, Rival Y, Genoux Y, Lampugnani MG, Dejana E (1996) Thrombin-induced increase in endothelial permeability is associated with changes in cell-to-cell junction organization. Arterioscler Thromb Vasc Biol 16(3): 488-496.
253. Kevil CG, Payne DK, Mire E, Alexander JS (1998) Vascular permeability factor/vascular endothelial cell growth factor-mediated permeability occurs through disorganization of endothelial junctional proteins. J Biol Chem 273(24): 15099-15103.
254. Esser S, Lampugnani MG, Corada M, Dejana E, Risau W (1998) Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells. J Cell Sci 111(Pt 13): 1853-1865.
255. Andriopoulou P, Navarro P, Zanetti A, Lampugnani MG, Dejana E (1999) Histamine induces tyrosine phosphorylation of endothelial cell-to-cell adherens junctions. Arterioscler Thromb Vasc Biol 19(10): 2286-2297.
256. Wong RK, Baldwin AL, Heimark RL (1999) Cadherin-5 redistribution at sites of TNF-alpha and IFN-gamma-induced permeability in mesenteric venules. Am J Physiol 276(2 Pt 2): H736-H748.
257. i. Am J Physiol 276(6 Pt 2): H1892-H1901.
258. 2+ signaling increases human vascular endothelial cell permeability. J Pharmacol Sci 95(2): 174-180.
259. 2-mediated vasodilatation involve differential [Ca2+]i responses. Am J Physiol Heart Circ Physiol 281(4): H1759-H1766.
260. 2 nucleotide receptor mediates tissue factor expression in human coronary artery endothelial cells. J Biol Chem 286: 27027-27038.
261. Wallez Y, Vilgrain I, Huber P (2006) Angiogenesis: the VE-cadherin switch. Trends Cardiovasc Med 16(2): 55-59.
262. Wallez Y, Huber P (2008) Endothelial adherens and tight junctions in vascular homeostasis, inflammation and angiogenesis. Biochim Biophys Acta 1778(3): 794-809.
263. Wallez Y, Cand F, Cruzalegui F, Wernstedt C, Souchelnytskyi S, Vilgrain I, Huber P (2007) Src kinase phosphorylates vascular endothelial-cadherin in response to vascular endothelial growth factor: identification of tyrosine 685 as the unique target site. Oncogene 26(7): 1067-1077.
264. Matsuyoshi N, Toda K, Horiguchi Y, Tanaka T, Nakagawa S, Takeichi M, Imamura S (1997) In vivo evidence of the critical role of cadherin-5 in murine vascular integrity. Proc Assoc Am Physicians 109(4): 362-371.
265. Gotsch U, Borges E, Bosse R, Boggemeyer E, Simon M, Mossmann H, Vestweber D (1997) VE-cadherin antibody accelerates neutrophil recruitment in vivo. J Cell Sci 110(Pt 5): 583-588.
266. Corada M, Mariotti M, Thurston G, Smith K, Kunkel R, Brockhaus M, Lampugnani MG, Martin-Padura I, Stoppacciaro A, Ruco L, McDonald DM, Ward PA, Dejana E (1999) Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo. Proc Natl Acad Sci U S A 96(17): 9815-9820.
267. Breviario F, Caveda L, Corada M, Martin-Padura I, Navarro P, Golay J, Introna M, Gulino D, Lampugnani MG, Dejana E (1995) Functional properties of human vascular endothelial cadherin (7B4/cadherin-5), an endothelium-specific cadherin. Arterioscler Thromb Vasc Biol 15(8): 1229-1239.
268. Vincent PA, Xiao K, Buckley KM, Kowalczyk AP (2004) VE-cadherin: adhesion at arm's length. Am J Physiol Cell Physiol 286(5): C987-C997.
269. Noren NK, Liu BP, Burridge K, Kreft B (2000) p120 catenin regulates the actin cytoskeleton via Rho family GTPases. J Cell Biol 150(3): 567-580.
270. Grosheva I, Shtutman M, Elbaum M, Bershadsky AD (2001) p120 catenin affects cell motility via modulation of activity of Rho-family GTPases: a link between cell-cell contact formation and regulation of cell locomotion. J Cell Sci 114(Pt 4): 695-707.
271. Anastasiadis PZ, Moon SY, Thoreson MA, Mariner DJ, Crawford HC, Zheng Y, Reynolds AB (2000) Inhibition of RhoA by p120 catenin. Nat Cell Biol 2(9): 637-644.
272. Lampugnani MG, Zanetti A, Breviario F, Balconi G, Orsenigo F, Corada M, Spagnuolo R, Betson M, Braga V, Dejana E (2002) VE-cadherin regulates endothelial actin activating Rac and increasing membrane association of Tiam. Mol Biol Cell 13(4): 1175-1189.
273. Baumeister U, Funke R, Ebnet K, Vorschmitt H, Koch S, Vestweber D (2005) Association of Csk to VE-cadherin and inhibition of cell proliferation. EMBO J 24(9): 1686-1695.
274. Nawroth R, Poell G, Ranft A, Kloep S, Samulowitz U, Fachinger G, Golding M, Shima DT, Deutsch U, Vestweber D (2002) VE-PTP and VE-cadherin ectodomains interact to facilitate regulation of phosphorylation and cell contacts. EMBO J 21(18): 4885-4895.
275. Dejana E, Bazzoni G, Lampugnani MG (1999) The role of endothelial cell-to-cell junctions in vascular morphogenesis. Thromb Haemost 82(2): 755-761.
276. Naik MU, Mousa SA, Parkos CA, Naik UP (2003) Signaling through JAM-1 and alphavbeta3 is required for the angiogenic action of bFGF: dissociation of the JAM-1 and alphavbeta3 complex. Blood 102(6): 2108-2114.
277. Aurrand-Lions M, Johnson-Leger C, Imhof BA (2002) The last molecular fortress in leukocyte trans-endothelial migration. Nat Immunol 3(2): 116-118.